Notice Type
Departmental
Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Aciclovir 25 mg/mL in 10 mL, 20 mL Solution for infusion, vial David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Aciclovir Intravenous Infusion Brimonidine tartrate 2 mg/mL in 2.5 mL, 5 mL, 10 mL Solution, ophthalmic (eye drops) Allergan America, Hormigueros, Puerto Rico Alphagan Dolasetron mesilate 25 mg, 50 mg, 100 mg, 200 mg Tablet, film coated Marion Merrell Dow Pharmaceuticals Inc., Cincinnati, Ohio, United States of America Anzemet Dolasetron mesilate 20 mg/mL in 0.625 mL, 1.25 mL, 2.5 mL, 5.0 mL, 10.0 mL Injection, Ampoule Gruppo Lepetit SpA., Anagni (Frosinone), Italy Anzemet Citric acid monohydrate 0.07% w/v in 50 mL, 250 mL Diluent, bottle McGaw Biomed Limited, Point Chevalier, Auckland Citric Acid Dextromethorphan hydrobromide 0.75 mg/mL, paracetamol 50 mg/mL, promethazine hydrochloride 1 mg/mL in 20 mL Solution, oral Wrafton Laboratories Limited, Wrafton, Braunton, North Devon, England Coldrex Night Relief Dapsone 100 mg Tablet Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia Dapsone Brompheniramine maleate 0.4 mg, dextromethorphan hydrobromide 2 mg, phenylephrine hydrochloride 1 mg per mL in 50 mL Solution, oral drops Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Dimetapp DM Cold and Cough Paediatric Drops Dimethicone 15% w/w, paraffin liquid light 10% w/w, zinc oxide 15% w/w in 50 g, 100 g Cream, skin Ego Pharmaceuticals Pty Limited, Braeside, Victoria, Austrlia Egozite Baby Cream Budesonide 2.25 mg, 3 mg Capsule, modified release Astra Production Tablets AB., Gartunavagen, Sodertalje, Sweden Entocort Amifostine 500 mg Injection, powder, vial Ben Venue Laboratories Inc., Bedford, Ohio, United States of America and USB Pharma bv., Nijmegen, The Netherlands Ethyol Caffeine 100 mg, nicotinic acid 10 mg, thiamine hydrochloride 10 mg Tablet Pan Laboratories Pty Limited, Villawood, New South Wales, Australia No Doz Plus Tramadol hydrochloride 50 mg Capsule Grunenthal GmbH., Stolberg, Germany Tramal Tramadol hydrochloride 50 mg/mL in 2 mL Solution, injection and infusion, ampoules Grunenthal GmbH., Stolberg, Germany Tramal 100 Tramadol hydrochloride 50 mg/mL in 1 mL Solution, injection and infusion, ampoules Grunenthal GmbH., Stolberg, Germany Tramal 50 Urokinase 5 000 IU, 25 000 IU, 100 000 IU, 500 000 IU, 1 000 000 IU Injection, powder for Industria Farmaceutica Serono SpA., Rome, Italy and Serono Pharma SpA., Bari, Italy Ukidan Capsaicin 0.025% w/w in 45 g Cream, skin Custom Pharmaceutical, Fort Erie, Ontario, Canada Zostrix Dated this 19th day of September 1997. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
Publication Date
25 Sep 1997

Notice Number

1997-go6738

Page Number

3245